- Learn what to include in a well-written protocol to ensure successful recruitment and data collection, as well as guidance for investigators and site staff new to immunotherapy trials.
- Understand how to select measurable endpoints and when to consider pharmacodynamic (PD) endpoints for bioequivalence studies.
- Gain an understanding of dosing and patient response challenges unique to immunotherapy trials, including dose-escalation, irRC versus RECIST, and pseudo disease progression.
- Recognize the distinct challenges smaller companies face when embarking on immunotherapy studies.
If the Mastering Oncology Immunotherapy Clinical Trials: The Smaller Biopharmaceutical Perspective is important to your business, act now and make the appropriate connections. See the contact information below.
|Conference/Event Dates:||05/05/2016 - 05/05/2016|
|Other Industries:||Cancer, Clinical Pharmacology, Oncology-Hematology, Professional Healthcare|
|Audience:||This webinar is intended for oncology professionals who oversee immuno-oncology drug development and clinical research in North America and Europe. Attendees may include:
VPs/Directors of Clinical Operations / Outsourcing / Procurement / Project Management / Study Management
Immuno-oncology/Oncology division leaders
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.